Johnson & Johnson has lost a lawsuit that claimed baby powder manufactured by the company was responsible for a deadly cancer linked to asbestos. The company, along with talc supplier Imerys SA, must pay at […]
Boehringer Ingelheim has formed an alliance with OSE Immunotherapeutics to develop a SIRP-alpha antagonist compound to treat advanced solid tumours. Under the collaboration and licence agreement, the companies will work together on the monoclonal antibody […]
Novartis has signed an agreement to purchase clinical-stage gene therapy company AveXis for $218 per share. Novartis has established an acquisition subsidiary, Novartis AM Merger, which will be integrated with AveXis following the closure of […]
Takeda Pharmaceutical has entered a partnership agreement with the Drugs for Neglected Diseases initiative (DNDi) to develop a drug for visceral leishmaniasis (VL). The organisations will perform preclinical and Phase I trials on drug candidates […]
A phase 3 study of Incyte’s epacadostat in combination with Merck’s Keytruda (pembrolizumab) in patients with unresectable or metastatic melanoma has failed meet to primary endpoint. The external data monitoring committee (eDMC) concluded that the […]